2009
DOI: 10.1016/j.tet.2009.09.054
|View full text |Cite
|
Sign up to set email alerts
|

Facile and practical synthesis of a cannabinoid-1 antagonist via regio- and stereoselective ring-opening of an aziridinium ion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 21 publications
0
6
0
Order By: Relevance
“…• General remarks: DMTMM has received little attention from process chemists, and only one example on scale was found in the literature. 133 Unlike CDMT, which may require acid preactivation to minimize coupling of the amine with the activator, DMTMM-mediated amide bond formation does not require acid preactivation and can be carried out in an all-in fashion. As for CDMT, the byproduct 1,3-dimethoxy-5-hydroxytriazine is watersoluble and easily purged during workup via acidic/ basic washes.…”
Section: O-[(cyano)(ethoxycarbonyl)methyleneamino]-nnn′n′-tetramethyl...mentioning
confidence: 99%
See 1 more Smart Citation
“…• General remarks: DMTMM has received little attention from process chemists, and only one example on scale was found in the literature. 133 Unlike CDMT, which may require acid preactivation to minimize coupling of the amine with the activator, DMTMM-mediated amide bond formation does not require acid preactivation and can be carried out in an all-in fashion. As for CDMT, the byproduct 1,3-dimethoxy-5-hydroxytriazine is watersoluble and easily purged during workup via acidic/ basic washes.…”
Section: O-[(cyano)(ethoxycarbonyl)methyleneamino]-nnn′n′-tetramethyl...mentioning
confidence: 99%
“…The only example of the use of DMTMM for amide bond formation was reported by Novartis in the USA, who used it for the preparation of cannabinoid-1 antagonist candidate 361 for the treatment of obesity and diabetes (Scheme 125). 133 Highlights of the amidation step leading to amide intermediate 360 are as follows:…”
Section: Ecf Case Studiesmentioning
confidence: 99%
“…This straightforward methodology would avoid the synthesis of isolated DMT-Ams(X), reduce production complexity, and solvent use and allow to achieve a library of dehydro-condensation agents, modulated according to specific requirements. Nowadays, a few data are available on dehydro-condensation reactions carried out with similar protocols [ 43 , 45 ] and often referring to very specific substrates in rather limited reaction conditions [ 46 , 47 , 48 , 49 , 50 ]. Only recently, Kitamura [ 34 ] and Kunishima [ 35 ] reported a similar protocol for amide condensation reactions, albeit in the presence of amido- or imido-chlorotriazines.…”
Section: Introductionmentioning
confidence: 99%
“…According to Table S5, the AMP x -promoted reactions have PMI RRC values ranging from about 3–10. The PMI RRC of the AMP im1 reaction is 3.5, which is similar to those using EDC (3.2), (4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM, 2.2), and COMU (3.7) but lower than that using pivaloyl chloride (PV, 11.4) (Scheme B). Considering that the AMP x coupling reactions require only a single reagent, it is simpler to set up compared to those requiring multiple reagents.…”
Section: Resultsmentioning
confidence: 53%